Neuropace Inc
NASDAQ:NPCE
Neuropace Inc
NASDAQ:NPCE
Price:
14.22
USD
1.21%
Market Cap:
$470.4m
Balance Sheet
Balance Sheet Decomposition
Neuropace Inc
Neuropace Inc
Balance Sheet Decomposition is not available for
Neuropace Inc
Neuropace Inc
Balance Sheet
Neuropace Inc
Neuropace Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
4
|
26
|
19
|
7
|
18
|
13
|
22
|
|
| Cash Equivalents |
4
|
26
|
19
|
7
|
18
|
13
|
22
|
|
| Short-Term Investments |
1
|
12
|
96
|
71
|
48
|
39
|
39
|
|
| Total Receivables |
6
|
8
|
7
|
8
|
12
|
13
|
15
|
|
| Accounts Receivables |
6
|
8
|
7
|
8
|
12
|
13
|
15
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
8
|
7
|
8
|
10
|
11
|
13
|
17
|
|
| Other Current Assets |
1
|
1
|
2
|
3
|
3
|
2
|
1
|
|
| Total Current Assets |
20
|
55
|
133
|
98
|
93
|
81
|
94
|
|
| PP&E Net |
1
|
1
|
1
|
16
|
14
|
13
|
11
|
|
| PP&E Gross |
1
|
1
|
1
|
16
|
14
|
13
|
11
|
|
| Accumulated Depreciation |
8
|
8
|
9
|
9
|
8
|
8
|
8
|
|
| Other Long-Term Assets |
0
|
1
|
0
|
1
|
1
|
0
|
0
|
|
| Total Assets |
21
N/A
|
56
+165%
|
134
+139%
|
114
-15%
|
108
-6%
|
95
-12%
|
106
+12%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
1
|
1
|
2
|
2
|
3
|
2
|
|
| Accrued Liabilities |
7
|
7
|
8
|
9
|
13
|
12
|
15
|
|
| Short-Term Debt |
19
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
44
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
5
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Total Current Liabilities |
75
|
10
|
9
|
11
|
16
|
15
|
18
|
|
| Long-Term Debt |
0
|
51
|
50
|
53
|
57
|
60
|
59
|
|
| Other Liabilities |
2
|
2
|
1
|
15
|
14
|
12
|
10
|
|
| Total Liabilities |
77
N/A
|
62
-19%
|
60
-4%
|
79
+32%
|
87
+10%
|
87
0%
|
87
0%
|
|
| Equity | ||||||||
| Common Stock |
74
|
141
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
364
|
388
|
424
|
471
|
504
|
531
|
552
|
|
| Additional Paid In Capital |
234
|
240
|
498
|
507
|
524
|
539
|
571
|
|
| Other Equity |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Equity |
56
N/A
|
6
+89%
|
74
N/A
|
35
-53%
|
21
-41%
|
8
-61%
|
19
+138%
|
|
| Total Liabilities & Equity |
21
N/A
|
56
+165%
|
134
+139%
|
114
-15%
|
108
-6%
|
95
-12%
|
106
+12%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
23
|
23
|
25
|
25
|
28
|
30
|
34
|
|
Switch to:
Switch to:
See Also
Discover More
